GI
ABBV icon

GLOBALT Investments’s AbbVie ABBV Stock Holding History

GLOBALT Investments’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.06M Sell
24,065
-396
-2% -$85.2K 0.2% 65
2026
Q1 		$5.32M Sell
24,461
-485
-2% -$108K 0.19% 66
2025
Q4 		$5.7M Sell
24,946
-859
-3% -$196K 0.21% 65
2025
Q3 		$5.97M Sell
25,805
-365
-1% -$74.3K 0.22% 65
2025
Q2 		$4.86M Buy
26,170
+3,178
+14% +$591K 0.19% 71
2025
Q1 		$4.82M Sell
22,992
-146
-0.6% -$28.4K 0.2% 74
2024
Q4 		$4.11M Buy
23,138
+3,982
+21% +$732K 0.16% 82
2024
Q3 		$3.78M Buy
+19,156
New +$3.58M 0.14% 86

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

GLOBALT Investments's ABBV Position: Q2 2026 in Review

GLOBALT Investments reduced its AbbVie (ABBV) stake by 1.6% in Q2 2026, selling an estimated $85.2K and leaving 24,065 shares worth $6.06M. The position accounts for 0.2% of the portfolio, ranked #65.

GLOBALT Investments first reported a position in ABBV in Q3 2024 and has held it in 8 quarters since. 4,193 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • GLOBALT Investments held 24,065 shares of AbbVie worth $6.06M as of Q2 2026.
  • GLOBALT Investments sold 396 AbbVie shares in Q2 2026, an estimated $85.2K.
  • AbbVie made up 0.2% of GLOBALT Investments's portfolio in Q2 2026, its #65 holding.
  • GLOBALT Investments first reported a position in AbbVie in Q3 2024 and has held it in 8 quarters since.
  • 4,193 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on GLOBALT Investments's 13F filing for Q2 2026, filed 11 Aug 2026.